Wealth Enhancement Trust Services’s Nuvation Bio NUVB Stock Holding History

Wealth Enhancement Trust Services’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25K	Buy	+220	New	+$1.07K	﹤0.01%	1072

Other funds holding NUVB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wealth Enhancement Trust Services's NUVB Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Nuvation Bio (NUVB) in Q2 2026: 220 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #1072 among its holdings.

141 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Wealth Enhancement Trust Services held 220 shares of Nuvation Bio worth $1.25K as of Q2 2026.
Nuvation Bio was a new Wealth Enhancement Trust Services position in Q2 2026.
Nuvation Bio made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1072 holding.
141 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.